Grant: Project Grant
University of Ottawa Institute of Mental Health Research
$948,600.00
A Tale of Two Targets: A Multisite, Randomized, Sham-Controlled Neurofeedback Clinical Trial Examining Regulation of the Amygdala vs. the Posterior Cingulate Cortex in PTSD
EF 2025-26
Résumé
Post-traumatic stress disorder (PTSD) is a serious mental health condition that affects over 1 million Canadians, including a significant number of military personnel and veterans. Many people with PTSD struggle to find effective treatment, as current therapies often do not work for everyone and have high dropout rates. This research aims to explore a new, science-based approach to PTSD treatment called real-time fMRI neurofeedback (rt-fMRI-NFB). This technique allows individuals to see and control their own brain activity in real-time, helping them learn to regulate brain regions linked to PTSD symptoms.
In this study, we will compare two key brain areas that may be important for PTSD recovery: the amygdala, which is involved in fear and emotional reactions, and the posterior cingulate cortex (PCC), which plays a role in self-reflection and memory processing. Participants, all military personnel or veterans with PTSD, will take part in three neurofeedback sessions over three weeks. They will be randomly assigned to receive training focused on the amygdala, the PCC, or a sham-control "placebo" brain signal, which will help us determine whether the observed clinical effects are truly due to neurofeedback. We will measure PTSD symptoms before, during, and after the sessions, with follow-ups at three and six months to see how lasting the effects are.
This study will provide critical insights into how neurofeedback influences PTSD symptoms and brain activity. By identifying which brain region is the best target for treatment and how many sessions are needed for meaningful improvement, our findings will help guide future clinical applications. Ultimately, this research could lead to new, personalized treatments for PTSD, improving mental health care for military personnel, veterans, and other communities affected by trauma.
Programme
Project Grant
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
566224
Name
Nicholson Andrew
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Behavioural Sciences - B-2
Projecttitle
A Tale of Two Targets: A Multisite, Randomized, Sham-Controlled Neurofeedback Clinical Trial Examining Regulation of the Amygdala vs. the Posterior Cingulate Cortex in PTSD
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa Institute of Mental Health Research
Cihramount2
$948,600
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Military Members; Neurofeedback; Neuroimaging; Post-Traumatic Stress Disorder; Psychiatry; Real-Time Fmri; Trauma; Veterans
Abstract
Post-traumatic stress disorder (PTSD) is a serious mental health condition that affects over 1 million Canadians, including a significant number of military personnel and veterans. Many people with PTSD struggle to find effective treatment, as current therapies often do not work for everyone and have high dropout rates. This research aims to explore a new, science-based approach to PTSD treatment called real-time fMRI neurofeedback (rt-fMRI-NFB). This technique allows individuals to see and control their own brain activity in real-time, helping them learn to regulate brain regions linked to PTSD symptoms.
In this study, we will compare two key brain areas that may be important for PTSD recovery: the amygdala, which is involved in fear and emotional reactions, and the posterior cingulate cortex (PCC), which plays a role in self-reflection and memory processing. Participants, all military personnel or veterans with PTSD, will take part in three neurofeedback sessions over three weeks. They will be randomly assigned to receive training focused on the amygdala, the PCC, or a sham-control "placebo" brain signal, which will help us determine whether the observed clinical effects are truly due to neurofeedback. We will measure PTSD symptoms before, during, and after the sessions, with follow-ups at three and six months to see how lasting the effects are.
This study will provide critical insights into how neurofeedback influences PTSD symptoms and brain activity. By identifying which brain region is the best target for treatment and how many sessions are needed for meaningful improvement, our findings will help guide future clinical applications. Ultimately, this research could lead to new, personalized treatments for PTSD, improving mental health care for military personnel, veterans, and other communities affected by trauma.
Competitiondate
202603
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Nicholson, Andrew
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $948,600~ $0~